HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanjib Sinha Selected Research

Hamartoma

1/2022Exploring immunoreactivity of TTF-1 and AVP in hypothalamic hamartoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanjib Sinha Research Topics

Disease

15Seizures (Absence Seizure)
05/2023 - 08/2008
8Epilepsy (Aura)
10/2023 - 05/2013
6Hepatolenticular Degeneration (Wilson's Disease)
03/2020 - 02/2005
5Hippocampal Sclerosis
01/2023 - 11/2014
5Brain Diseases (Brain Disorder)
12/2022 - 07/2011
4Temporal Lobe Epilepsy
01/2023 - 11/2016
4Guillain-Barre Syndrome
05/2022 - 10/2018
4Juvenile Myoclonic Epilepsy
01/2017 - 04/2013
3Infections
05/2022 - 09/2018
3Status Epilepticus (Complex Partial Status Epilepticus)
03/2022 - 01/2015
3Disease Progression
01/2022 - 01/2014
3Encephalitis (Encephalitis, Rasmussen)
05/2021 - 01/2016
3Partial Epilepsies (Epilepsy, Partial)
11/2020 - 08/2013
3Disorders of Excessive Somnolence (Hypersomnia)
02/2017 - 07/2015
2Meningitis
01/2023 - 10/2020
2Myasthenia Gravis
09/2022 - 05/2019
2Epilepsia Partialis Continua
05/2022 - 07/2008
2Dengue (Dengue Fever)
05/2022 - 01/2021
2Mitochondrial Diseases (Mitochondrial Disease)
06/2021 - 01/2021
2Demyelinating Diseases (Demyelinating Disease)
12/2020 - 02/2018
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020 - 05/2013
2Cerebellar Diseases (Cerebellar Syndrome)
12/2013 - 07/2011
1Neurodevelopmental Disorders
10/2023
1Channelopathies
10/2023
1Epileptic Syndromes
10/2023
1Neurocysticercosis
05/2023
1Osteomyelitis
01/2023
1Hematoma
01/2023
1Surgical Wound Infection
01/2023
1Infantile Spasms (West Syndrome)
12/2022
1Japanese Encephalitis
05/2022
1Human Influenza (Influenza)
05/2022
1Ring Chromosome 20 Syndrome
03/2022
1Precocious Puberty
01/2022
1Hypothalamic hamartomas
01/2022
1Hamartoma
01/2022
1Leukoencephalopathies
01/2022
1Gliosis
12/2021
1Mitochondrial Myopathies (Mitochondrial Myopathy)
11/2021
1Polymicrogyria
09/2021
1Cysticercosis
09/2021
1Vascular Malformations
09/2021
1MELAS Syndrome (Syndrome, MELAS)
06/2021
1Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
05/2021
1Autoimmune Diseases of the Nervous System
05/2021
1Neuromuscular Diseases (Neuromuscular Disease)
01/2021
1Fibrosis (Cirrhosis)
12/2020
1Headache (Headaches)
11/2020
1Cough
11/2020
1Sporadic Creutzfeldt-Jakob Disease
11/2020
1Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2020
1Generalized Epilepsy
11/2020
1Fungal Meningitis
10/2020
1Leukocytosis (Pleocytosis)
10/2020
1Drug Resistant Epilepsy
11/2019
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
05/2019

Drug/Important Bio-Agent (IBA)

6SteroidsIBA
12/2022 - 07/2011
5Valproic Acid (Depakote)FDA LinkGeneric
02/2019 - 10/2015
4Biomarkers (Surrogate Marker)IBA
05/2023 - 01/2015
4MethylprednisoloneFDA LinkGeneric
12/2022 - 07/2021
4EnzymesIBA
11/2021 - 08/2013
4Carbamazepine (Tegretol)FDA LinkGeneric
09/2018 - 07/2016
4Anticonvulsants (Antiepileptic Drugs)IBA
01/2017 - 08/2008
3AntibodiesIBA
05/2022 - 07/2011
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2021 - 01/2016
3CopperIBA
01/2019 - 05/2013
2SodiumIBA
10/2023 - 10/2015
2Rituximab (Mabthera)FDA Link
09/2022 - 12/2013
2erucylphosphocholineIBA
05/2022 - 07/2008
2GangliosidesIBA
05/2022 - 12/2020
2Immunoglobulin E (IgE)IBA
11/2020 - 04/2013
2Proteins (Proteins, Gene)FDA Link
11/2020 - 10/2020
2Lactic Acid (Lactate)FDA LinkGeneric
02/2018 - 07/2014
2Prednisolone (Predate)FDA LinkGeneric
01/2017 - 01/2016
2Ceruloplasmin (Ferroxidase)IBA
10/2016 - 05/2013
2Indicators and Reagents (Reagents)IBA
03/2014 - 08/2008
1Sodium Channels (Sodium Channel)IBA
10/2023
1Hormones (Hormone)IBA
01/2022
1Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
1mitomycin C-dextranIBA
09/2021
1DNA (Deoxyribonucleic Acid)IBA
06/2021
1Immunoglobulin G (IgG)IBA
06/2021
1Aquaporins (Water Channels)IBA
06/2021
1AlbuminsIBA
06/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021
1Mitochondrial DNA (mtDNA)IBA
06/2021
1Melanins (Melanin)IBA
05/2021
1Growth Differentiation Factor 15IBA
01/2021
1ImmunosorbentsIBA
01/2021
1fibroblast growth factor 21IBA
01/2021
1Luxol Fast Blue MBS (Luxol fast blue)IBA
12/2020
1VimentinIBA
12/2020
1brivaracetamIBA
11/2020
1Glucose (Dextrose)FDA LinkGeneric
10/2020
1AutoantibodiesIBA
05/2019

Therapy/Procedure

10Therapeutics
03/2022 - 10/2007
3Anterior Temporal Lobectomy
01/2023 - 10/2018
2Length of Stay
01/2017 - 08/2013
1Craniotomy
01/2023